Abstract
Plantamajoside is a phenylpropanoid glycoside that can be extracted from Plantago asiatica L., Plantaginaceae. It is one of the most extensively researched compounds due to its strong affinity and potency with diverse biological functions and significant therapeutic potential. It possesses anti-tumor, anti-inflammatory, diuretic, wound-healing, anti-asthmatic, hepatoprotective, anti-aging, and neuroprotective activities and is effective for acute lung injury and acute spinal cord injury. It is also employed as a biomarker in chemotaxonomy investigations. This review assembles the current knowledge of plantamajoside’s potential benefits and applications for human health. It may inspire the medicinal and natural product chemists to further explore the potential of plantamajoside.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abe F, Nagao T, Okabe H (2002) Antiproliferative constituents in plants 9. Aerial parts of Lippia dulcis and Lippia canescens. Biol Pharm Bull 25:920–922. https://doi.org/10.1248/bpb.25.920
Bai L, Han L, Lu X, Kang X, Fan Z, Xing R, Zhou D (2017) UHPLC-MS/MS determination and pharmacokinetic study of plantamajoside in rat plasma after oral administration of single plantamajoside and Plantago asiatica extract. Biomed Chromatogr 31:e3883. https://doi.org/10.1002/bmc.3883
Budzianowska A, Skrzypczak L, Budzianowski J (2004) Phenylethanoid glucosides from in vitro propagated plants and callus cultures of Plantago lanceolata. Planta Med 70:834–840. https://doi.org/10.1055/s-2004-827232
Cekici A, Kantarci A, Hasturk H, Van Dyke TE (2014) Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000(64):57–80. https://doi.org/10.1111/prd.12002
Cepas V, Collino M, Mayo JC, Sainz RM (2020) Redox signaling and advanced glycation endproducts (AGEs) in diet-related diseases. Antioxidants 9:142–162. https://doi.org/10.3390/antiox9020142
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2018) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9:7204–7218. https://doi.org/10.18632/oncotarget.23208
Choi S-Y, Jung S-H, Lee H-S, Park K-W, Yun B-S, Lee K-W (2008) Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract. Phyther Res 22:323–329. https://doi.org/10.1002/ptr.2316
Cukic V, Lovre V, Dragisic D, Ustamujic A (2012) Asthma and chronic obstructive pulmonary disease (COPD)-Differences and similarities. Mat Soc Med 24:100–105. https://doi.org/10.5455/msm.2012.24.100-105
Fitzsimmons TR, Ge S, Bartold PM (2018) Compromised inflammatory cytokine response to P. gingivalis LPS by fibroblasts from inflamed human gingiva. Clin Oral Investig 22:919–927. https://doi.org/10.1007/s00784-017-2171-6
Fleer H, Verspohl EJ (2007) Antispasmodic activity of an extract from Plantago lanceolata L. and some isolated compounds. Phytomedicine 14:409–415. https://doi.org/10.1016/j.phymed.2006.05.006
Genc Y, Dereli FTG, Saracoglu I, Akkol EK (2020) The inhibitory effects of isolated constituents from Plantago major subsp. major L. on collagenase, elastase and hyaluronidase enzymes: Potential wound healer. Saudi Pharm J 28:101–106. https://doi.org/10.1016/j.jsps.2019.11.011
Geng F, Yang L, Chou G, Wang Z (2010) Bioguided isolation of angiotensin-converting enzyme inhibitors from the seeds of Plantago asiatica L. Phyther Res 24:1088–1094. https://doi.org/10.1002/ptr.3071
Gonda S, Nguyen NM, Batta G, Gyémánt G, Máthé C, Vasas G (2013) Determination of phenylethanoid glycosides and iridoid glycosides from therapeutically used Plantago species by CE-MEKC. Electrophoresis 34:2577–2584. https://doi.org/10.1002/elps.201300121
Gonda S, Kiss-Szikszai A, Szucs Z, Máthé C, Vasas G (2014) Effects of N source concentration and NH4+/NO3- ratio on phenylethanoid glycoside pattern in tissue cultures of Plantago lanceolata L.: a metabolomics driven full-factorial experiment with LC-ESI-MS3. Phytochemistry 106:44–54. https://doi.org/10.1016/j.phytochem.2014.07.002
Guo H, Feng C, Hu L, Zhao X, Tang X, Huang Y, Luo J, Xu M, Xie W (2022) Exploration of a ternary deep eutectic solvent for the efficient extraction of plantamajoside, acteoside, quercetin and kaempferol from Plantago asiatica L. Phytochem Anal 33:94–104. https://doi.org/10.1002/pca.3071
Han A-R, Nam M-H, Lee K-W (2016) Plantamajoside inhibits UVB and advanced glycation end products-induced MMP-1 expression by suppressing the MAPK and NF- κB pathways in HaCaT cells. Photochem Photobiol 92:708–719. https://doi.org/10.1111/php.12615
How KY, Song KP, Chan KG (2016) Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol 7:53–66. https://doi.org/10.3389/fmicb.2016.00053
Hu H, Jian X (2021) The protective mechanism of action of plantamajoside on a rat model of acute spinal cord injury. Exp Ther Med 21:378–384. https://doi.org/10.3892/etm.2021.9809
Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91:221–264. https://doi.org/10.1152/physrev.00052.2009
Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y (2019) Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer 18:157–171. https://doi.org/10.1186/s12943-019-1089-9
Johnson ER, Matthay MA (2010) Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 23:243–252. https://doi.org/10.1089/jamp.2009.0775
Jung HY, Seo DW, Hong CO, Kim JY, Yang SY, Lee KW (2015) Nephroprotection of plantamajoside in rats treated with cadmium. Environ Toxicol Pharmacol 39:125–136. https://doi.org/10.1016/j.etap.2014.11.012
Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428. https://doi.org/10.1172/JCI39104
Kee HJ, Eom GH, Joung H, Shin S, Kim JR, Cho YK, Choe N, Sim BW, Jo D, Jeong MH, Kim KK, Seo JS, Kook H (2008) Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy. Circ Res 103:1259–1269. https://doi.org/10.1161/01.RES.0000338570.27156.84
Key TJ, Bradbury KE, Perez-Cornago A, Sinha R, Tsilidis KK, Tsugane S (2020) Diet, nutrition, and cancer risk: what do we know and what is the way forward? BMJ 368:m511. https://doi.org/10.1136/bmj.m511
Li L, Liu CM, Liu ZQ, Wang J (2008) Isolation and purification of phenylethanoid glycosides from plant extract of Plantago asiatica by high performance centrifugal partition chromatography. Chin Chem Lett 19:1349–1352. https://doi.org/10.1016/j.cclet.2008.09.002
Li L, Liu C, Liu Z, Tsao R, Liu S (2009) Identification of phenylethanoid glycosides in plant extract of Plantago asiatica L. by liquid chromatography-electrospray ionization mass spectrometry. Chin J Chem 27:541–545. https://doi.org/10.1002/cjoc.200990088
Li Y, Gan L, Li GQ, Deng L, Zhang X, Deng Y (2014) Pharmacokinetics of plantamajoside and acteoside from Plantago asiatica in rats by liquid chromatography–mass spectrometry. J Pharm Biomed Anal 89:251–256. https://doi.org/10.1016/j.jpba.2013.11.014
Li X, Chen D, Li M, Gao X, Shi G, Zhao H (2018) Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells. Biomed Pharmacother 102:1045–1051. https://doi.org/10.1016/j.biopha.2018.03.171
Liu F, Huang X, He J j, Song C, Peng L, Chen T, Wu B l (2019) Plantamajoside attenuates inflammatory response in LPS-stimulated human gingival fibroblasts by inhibiting PI3K/AKT signaling pathway. Microb Pathog 127:208–211. https://doi.org/10.1016/j.micpath.2018.11.034
Long X, Kim Y, Pyo Y, Yi R, Zhao X, Park K (2020) Inhibitory effect of Jangkanghwan (Korean traditional food) on experimental ulcerative colitis in mice. J Food Biochem 44:13488–13503. https://doi.org/10.1111/jfbc.13488
Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3:a005058–a005058. https://doi.org/10.1101/cshperspect.a005058
Luo S, Jiang X, Yin G, Liu Y, Liu Z, Meng L, Wu J, Wu H (2021) The herbal agent plantamajoside, exerts a potential inhibitory effect on the development of hepatocellular carcinoma. Exp Ther Med 21:573–583. https://doi.org/10.3892/etm.2021.10005
Ma C, Ma W (2018) Plantamajoside inhibits lipopolysaccharide-induced MUC5AC expression and inflammation through suppressing the PI3K/Akt and NF-κB signaling pathways in human airway epithelial cells. Inflammation 41:795–802. https://doi.org/10.1007/s10753-018-0733-7
Muz B, de la Puente P, Azab F, Azab AK (2015) The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 3:83–92. https://doi.org/10.2147/HP.S93413
Park B-G, Lee H-S, Jung S-H, Hong C-O, Won H-J, Park H-Y, Ryu Y-S, Lee S-J, Kim K-H, Park K-W, Lee K-W (2007) A 90 day repeated oral toxicity study on plantamajoside concentrate from Plantago asiatica. Phytother Res 21:1118–1123. https://doi.org/10.1002/ptr.2217
Paz Velázquez Fiz M, Díaz Lanza AM, Fernández Matellano L (2000) Polyphenolic compounds from Plantago lagopus L. Z Naturforsch C 55:877–880. https://doi.org/10.1515/znc-2000-11-1205
Pei S, Yang X, Wang H, Zhang H, Zhou B, Zhang D, Lin D (2015) Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2. BMC Cancer 15:965–976. https://doi.org/10.1186/s12885-015-1960-z
Puche JE, Saiman Y, Friedman SL (2013) Hepatic stellate cells and liver fibrosis. Compr Physiol 3:1473–1492. https://doi.org/10.1002/cphy.c120035
Qi M, Xiong A, Geng F, Yang L, Wang Z (2012) A novel strategy for target profiling analysis of bioactive phenylethanoid glycosides in Plantago medicinal plants using ultra-performance liquid chromatography coupled with tandem quadrupole mass spectrometry. J Sep Sci 35:1470–1478. https://doi.org/10.1002/jssc.201200010
Ravn H, Brimer L (1988) Structure and antibacterial activity of plantamajoside, a caffeic acid sugar ester from Plantago major subsp. major. Phytochemistry 27:3433–3437. https://doi.org/10.1016/0031-9422(88)80744
Ravn HW, Mondolot L, Kelly MT, Lykke AM (2015) Plantamajoside-a current review. Phytochem Lett 12:42–53. https://doi.org/10.1016/j.phytol.2015.02.002
Rodrigo R, Libuy M, Feliú F, Hasson D (2013) Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers 35:773–790. https://doi.org/10.1155/2013/974358
Shang L, Pin L, Zhu S, Zhong X, Zhang Y, Shun M, Liu Y, Hou M (2019) Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway. Chem Biol Interact 307:21–28. https://doi.org/10.1016/j.cbi.2019.04.024
Son W, Nam M-H, Hong C-O, Kim Y, Lee K-W (2017) Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-κB. BMC Complement Altern Med 17:66–77. https://doi.org/10.1186/s12906-017-1570-1
Sun Q, Geng F, Cheng X, Yang L, Wang Z (2010) Qualitative and quantitative analysis of plantamajoside in Plantaginis herba. China J Chinese Mater Medica 35:2095–2098. https://doi.org/10.4268/CJCMM20101612
Tong R-C, Qi M, Yang Q-M, Li P-F, Wang D-D, Lan J-P, Wang Z-T, Yang L (2019) Extract of Plantago asiatica L. seeds ameliorates hypertension in spontaneously hypertensive rats by inhibition of angiotensin converting enzyme. Front Pharmacol 10:403–414. https://doi.org/10.3389/fphar.2019.00403
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet. 389:1756–1770. https://doi.org/10.1016/S0140-6736(16)32126-2
Vlassara H, Uribarri J (2014) Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep 14:453–470. https://doi.org/10.1007/s11892-013-0453-1
Wang Y, Yan D (2019) Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation. Exp Ther Med 18:2421–2428. https://doi.org/10.3892/etm.2019.7843
Wang Y, Liu M, Chen S, Wu Q (2020) Plantamajoside represses the growth and metastasis of malignant melanoma. Exp Ther Med 19:2296–2302. https://doi.org/10.3892/etm.2020.8442
World Health Organization (2013) A global brief on hypertension: silent killer, global public health crisis. World Health Day 2013 (No. WHO/DCO/WHD/2013.2). World Health Organization. https://www.who.int/publications/i/item/a-global-brief-on-hypertension-silent-killer-global-public-health-crisis-world-health-day-2013
Wu H, Zhao G, Jiang K, Chen X, Zhu Z, Qiu C, Li C, Deng G (2016) Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation. Int Immunopharmacol 35:315–322. https://doi.org/10.1016/j.intimp.2016.04.013
Xiao D, Yang R, Gong L, Zhang Y, Xie Y, Ni S (2021) Plantamajoside inhibits high glucose-induced oxidative stress, inflammation, and extracellular matrix accumulation in rat glomerular mesangial cells through the inactivation of Akt/NF-κB pathway. J Recept Signal Transduct 41:45–52. https://doi.org/10.1080/10799893.2020.1784939
Xu W-W, Guan M-P, Zheng Z-J, Gao F, Zeng Y-M, Qin Y, Xue Y-M (2014) Exendin-4 alleviates high glucose-induced rat mesangial cell dysfunction through the AMPK pathway. Cell Physiol Biochem 33:423–432. https://doi.org/10.1159/000358623
Xu Z, Zhao Y, Zhong P, Wang J, Weng Q, Qian Y, Han J, Zou C, Liang G (2017) EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress. Oncotarget 8:32655–32667. https://doi.org/10.18632/oncotarget.15948
Yin W, Xu J, Li C, Dai X, Wu T, Wen J (2020) Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression. Cell Biol Int 44:1616–1627. https://doi.org/10.1002/cbin.11354
Yoo T-K, Jeong WT, Kim JG, Ji HS, Ahn M-A, Chung J-W, Lim HB, Hyun TK (2021) UPLC-ESI-Q-TOF-MS-based metabolite profiling, antioxidant and anti-inflammatory properties of different organ extracts of Abeliophyllum distichum. Antioxidants 10:70. https://doi.org/10.3390/antiox10010070
Zan Y, Dai Z, Liang L, Deng Y, Dong L (2019) Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment. Drug Deliv 26:1080–1091. https://doi.org/10.1080/10717544.2019.1654040
Zeng G, An H, Fang D, Wang W, Han Y, Lian C (2020) Plantamajoside protects H9c2 cells against hypoxia/reoxygenation-induced injury through regulating the akt/Nrf2/HO-1 and NF-κB signaling pathways. J Recept Signal Transduct:1–8. https://doi.org/10.1080/10799893.2020.1859534
Zhu T-F, Yang Z-F, Yang Y-J, Chen L-S, Hu J-J, Yan Z-H, Jiang K (2014) Two new secoiridoid glycosides from the roots of Picrorhiza scrophulariiflora. Chem Nat Compd 50:248–250 0009-3130/14/5002-0281
Živković JČ, Barreira JCM, Šavikin KP, Alimpić AZ, Stojković DS, Dias MI, Santos-Buelga C, Duletić-Laušević SN, Ferreira ICFR (2017) Chemical profiling and assessment of antineurodegenerative and antioxidant properties of Veronica teucrium L. and Veronica jacquinii baumg. Chem Biodivers 14:e1700167. https://doi.org/10.1002/cbdv.201700167
Zou X, Liao X, Ding LS, Peng SL (2007) Phenyl and phenylethyl glycosides from Picrorhiza scrophulariiflora. J Asian Nat Prod Res 9:443–448. https://doi.org/10.1080/10286020500479946
Zuo X, Li L, Sun L (2021) Plantamajoside inhibits hypoxia-induced migration and invasion of human cervical cancer cells through the NF-κB and PI3K/akt pathways. J Recept Signal Transduct 41:339–348. https://doi.org/10.1080/10799893.2020.1808679
Zubair M, Nybom H, Lindholm C, Brandner JM, Rumpunen K (2016) Promotion of wound healing by Plantago major L. leaf extracts - ex-vivo experiments confirm experiences from traditional medicine. Nat Prod Res 30:622–624. https://doi.org/10.1080/14786419.2015.1034714
Zürn M, Tóth G, Ausbüttel T, Mucsi Z, Horváti K, Bősze S, Sütöri-Diószegi M, Pályi B, Kis Z, Noszál B, Boldizsár I (2021) Tissue-specific accumulation and isomerization of valuable phenylethanoid glycosides from Plantago and Forsythia plants. Int J Mol Sci 22:3880–3898. https://doi.org/10.3390/ijms22083880
Acknowledgements
We are thankful to BioRender for providing the platform to create professional science figures.
Author information
Authors and Affiliations
Contributions
AG designed the layout of the manuscript. PSK and NA collected the relevant data from different search engines. All the authors contributed equally to the writing of the manuscript. They have read and approved the final submission.
Corresponding author
Ethics declarations
Ethics approval
For this type of study, it is not required.
Conflict of interest
The authors declare no competing interests.
Supplementary information
ESM 1
(PDF 118 kb)
Rights and permissions
About this article
Cite this article
Goyal, A., Kushwah, P.S. & Agrawal, N. Therapeutic Potential of Plantamajoside. Rev. Bras. Farmacogn. 32, 355–364 (2022). https://doi.org/10.1007/s43450-022-00252-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43450-022-00252-y